Log in

Prestige Consumer Healthcare Stock Forecast, Price & News

-0.33 (-0.96 %)
(As of 10/23/2020 12:00 AM ET)
Today's Range
Now: $34.17
50-Day Range
MA: $35.98
52-Week Range
Now: $34.17
Volume207,400 shs
Average Volume456,210 shs
Market Capitalization$1.71 billion
P/E Ratio11.43
Dividend YieldN/A
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief. It also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, Fess nasal saline spray, and Hydralyte for oral rehydration products. The company sells through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Read More
Prestige Consumer Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.55 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPersonal Products



Sales & Book Value

Annual Sales$963.01 million
Cash Flow$3.59 per share
Book Value$23.30 per share


Net Income$142.28 million


Market Cap$1.71 billion
Next Earnings Date11/5/2020 (Confirmed)
-0.33 (-0.96 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PBH News and Ratings via Email

Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions

How has Prestige Consumer Healthcare's stock been impacted by COVID-19?

Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PBH shares have decreased by 4.8% and is now trading at $34.17.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Prestige Consumer Healthcare?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Prestige Consumer Healthcare

When is Prestige Consumer Healthcare's next earnings date?

Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Prestige Consumer Healthcare

How can I listen to Prestige Consumer Healthcare's earnings call?

Prestige Consumer Healthcare will be holding an earnings conference call on Thursday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc. (NYSE:PBH) announced its earnings results on Thursday, August, 6th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.70 by $0.16. The business had revenue of $229.40 million for the quarter, compared to the consensus estimate of $221.27 million. Prestige Consumer Healthcare had a net margin of 15.84% and a return on equity of 13.81%. The business's revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.65 earnings per share.
View Prestige Consumer Healthcare's earnings history

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare updated its second quarter earnings guidance on Thursday, August, 6th. The company provided earnings per share guidance of $0.70 or more for the period, compared to the Thomson Reuters consensus estimate of $0.71. The company issued revenue guidance of $225 million or more, compared to the consensus revenue estimate of $236.06 million.

What price target have analysts set for PBH?

7 brokerages have issued twelve-month target prices for Prestige Consumer Healthcare's shares. Their forecasts range from $43.00 to $97.00. On average, they anticipate Prestige Consumer Healthcare's stock price to reach $69.00 in the next twelve months. This suggests a possible upside of 101.9% from the stock's current price.
View analysts' price targets for Prestige Consumer Healthcare

Who are some of Prestige Consumer Healthcare's key competitors?

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA).

Who are Prestige Consumer Healthcare's key executives?

Prestige Consumer Healthcare's management team includes the following people:
  • Mr. Ronald M. Lombardi, Chairman, Pres & CEO (Age 56, Pay $1.98M)
  • Ms. Christine Sacco, Chief Financial Officer (Age 44, Pay $930.5k)
  • Mr. Jeffrey Zerillo, Sr. VP of Operations (Age 59, Pay $480.41k)
  • Mr. William C. P'Pool, Sr. VP, Gen. Counsel & Corp. Sec. (Age 55, Pay $735.71k)
  • Mr. Adel Mekhail, Exec. VP of Marketing & Sales (Age 59, Pay $679.38k)

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by many different retail and institutional investors. Top institutional shareholders include LSV Asset Management (1.45%), Wedge Capital Management L L P NC (0.57%), Dalton Greiner Hartman Maher & Co. (0.36%), Peregrine Capital Management LLC (0.27%), Skyline Asset Management LP (0.18%) and Nisa Investment Advisors LLC (0.05%). Company insiders that own Prestige Consumer Healthcare stock include Paton Brett, Ronald M Lombardi and Timothy Connors.
View institutional ownership trends for Prestige Consumer Healthcare

Which institutional investors are selling Prestige Consumer Healthcare stock?

PBH stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Peregrine Capital Management LLC, Nisa Investment Advisors LLC, Envestnet Asset Management Inc., Denali Advisors LLC, State of Alaska Department of Revenue, and Skyline Asset Management LP.
View insider buying and selling activity for Prestige Consumer Healthcare

Which institutional investors are buying Prestige Consumer Healthcare stock?

PBH stock was acquired by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., Wedge Capital Management L L P NC, Bowling Portfolio Management LLC, LSV Asset Management, Foundry Partners LLC, and Diversified Trust Co.
View insider buying and selling activity for Prestige Consumer Healthcare

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $34.17.

How big of a company is Prestige Consumer Healthcare?

Prestige Consumer Healthcare has a market capitalization of $1.71 billion and generates $963.01 million in revenue each year. The company earns $142.28 million in net income (profit) each year or $2.96 on an earnings per share basis. Prestige Consumer Healthcare employs 520 workers across the globe.

What is Prestige Consumer Healthcare's official website?

The official website for Prestige Consumer Healthcare is www.prestigebrands.com.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.